ÂÜÀòÂÒÂ×

Carol Chuang, PhD, has extensive experience in oncology and medical science, beginning as a Predoctoral Fellow at Baylor College of Medicine from 2006 to 2012. They progressed to roles such as Clinical Research Program Coordinator and Director, Medical Science Liaison at Eli Lilly and Company, where they served from 2019 to 2022. Carol also held roles at Global Patent Solutions LLC and MD Anderson Cancer Center, before returning to Eli Lilly as a Sr. Advisor in 2025. They earned a PhD from Baylor College of Medicine and a BS from St. Mary's University.